An All-Oral 6-Month Regimen for Multidrug-Resistant Tuberculosis: A Multicenter, Randomized Controlled Clinical Trial (the NExT Study).
Am J Respir Crit Care Med
; 205(10): 1214-1227, 2022 05 15.
Article
in En
| MEDLINE
| ID: mdl-35175905
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Tuberculosis, Multidrug-Resistant
/
Drug-Related Side Effects and Adverse Reactions
Type of study:
Clinical_trials
Limits:
Adult
/
Humans
Language:
En
Journal:
Am J Respir Crit Care Med
Journal subject:
TERAPIA INTENSIVA
Year:
2022
Document type:
Article
Affiliation country:
South Africa
Country of publication:
United States